FDA Approved: ENTRESTO — Original Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

FDA approves ENTRESTO (sacubitril/valsartan) under an original application from Novartis. The drug is indicated for treatment of heart failure with reduced ejec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Reduced Ejection Fraction

Drugs mentioned

• Entresto (sacubitril/valsartan)

Snippet

ORIG AP for ENTRESTO (SACUBITRIL AND VALSARTAN)